Skip to content

The Copper T380A IUD vs. Oral Levonorgestrel for Emergency Contraception

Preventing Future Pregnancy After Choosing the Copper IUD vs. Oral Levonorgestrel for Emergency Contraception

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00966771
Acronym
IUD EC
Enrollment
548
Registered
2009-08-27
Start date
2009-10-31
Completion date
2011-08-31
Last updated
2017-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy

Keywords

contraception, emergency contraception, pregnancy prevention after unprotected intercourse

Brief summary

The purpose of this study is to see if women presenting for emergency contraception (EC) and choose the copper intrauterine device (IUD) will have fewer unplanned pregnancies in the next year compared to women who choose oral levonorgestrel for EC. The study will also compare use of an effective method of contraception in the year after they received EC.

Detailed description

All women presenting to 2 Planned Parenthood Association of Utah clinics in Salt Lake City will be offered participation in this study. Women will select either the copper IUD or oral levonorgestrel for EC. The primary outcome is unplanned pregnancy in the year following presentation for EC. Secondary outcomes include use of an effective method of contraception over the next year, abortions, repeat use of EC, number of days to first bleeding episode and duration of that bleeding episode, use of a barrier method to prevent sexually transmitted infections, patient satisfaction with the chosen method of EC and contraception. Participants selecting the IUD will be assessed for IUD expulsion, perforation, and removal.

Interventions

copper T 380 IUD

DRUGOral levonorgestrel

1.5 mg

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
Society of Family Planning
CollaboratorOTHER
University of Utah
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Women 18-30 years old, * in need of emergency contraception (had unprotected intercourse within 120 hours), * willing to give consent for participation in research, * willing to comply with study requirements, and * accessible by telephone. Participants selecting the IUD need to identify themselves as desiring long-term contraception.

Exclusion criteria

* Current pregnancy * Had pelvic inflammatory disease or septic abortion within the past 3 months or had gonorrhea or chlamydia infection in the last 60 days * Current behavior suggesting a high risk for pelvic inflammatory disease * Allergy to copper or Wilson's disease (for participants selecting the copper IUD) or allergy to levonorgestrel (for participants selecting oral levonorgestrel) * Abnormalities of the uterus that distort the uterine cavity * Mucopurulent cervicitis * A previously placed IUD that has not been removed * Genital bleeding of an unknown etiology * Ovarian, cervical, or endometrial cancer * Small uterine cavity (\< 6cm)

Design outcomes

Primary

MeasureTime frame
Unplanned pregnancywithin 12 months of presenting for EC

Secondary

MeasureTime frame
Use of an effective method of contraception in the year following use of emergency contraception.12 months
IUD expulsion, removal or perforation12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026